The GLOVe regimen, combining glofitamab, lenalidomide, and venetoclax, shows rapid and deep responses in high-risk MCL patients with manageable toxicity. All evaluable patients achieved complete ...
Please provide your email address to receive an email when new articles are posted on . Historically, combined ACL and MCL injuries were often treated with open surgical approaches with much resultant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results